323.58
Schlusskurs vom Vortag:
$326.97
Offen:
$324.5
24-Stunden-Volumen:
745.48K
Relative Volume:
1.17
Marktkapitalisierung:
$22.78B
Einnahmen:
$2.36B
Nettoeinkommen (Verlust:
$236.10M
KGV:
98.35
EPS:
3.29
Netto-Cashflow:
$382.50M
1W Leistung:
-2.98%
1M Leistung:
-1.65%
6M Leistung:
+18.65%
1J Leistung:
+35.50%
Insulet Corporation Stock (PODD) Company Profile
Firmenname
Insulet Corporation
Sektor
Branche
Telefon
978-600-7000
Adresse
100 NAGOG PARK, ACTON, MA
Vergleichen Sie PODD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
PODD
Insulet Corporation
|
323.58 | 23.02B | 2.36B | 236.10M | 382.50M | 3.29 |
![]()
ABT
Abbott Laboratories
|
133.31 | 233.03B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
98.14 | 145.30B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
368.57 | 141.92B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
94.30 | 122.80B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
75.27 | 43.83B | 5.69B | 1.41B | 577.90M | 6.95 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-08 | Fortgesetzt | Oppenheimer | Outperform |
2025-06-16 | Eingeleitet | Truist | Buy |
2025-05-30 | Eingeleitet | Goldman | Buy |
2025-05-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2025-04-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2025-03-06 | Eingeleitet | RBC Capital Mkts | Outperform |
2024-11-06 | Eingeleitet | Bernstein | Outperform |
2024-05-30 | Eingeleitet | Redburn Atlantic | Buy |
2024-05-07 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2023-12-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2023-10-02 | Hochstufung | Jefferies | Hold → Buy |
2023-08-21 | Hochstufung | Citigroup | Neutral → Buy |
2023-08-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
2023-01-26 | Eingeleitet | Wolfe Research | Peer Perform |
2022-11-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
2022-10-18 | Eingeleitet | Barclays | Equal Weight |
2022-10-12 | Eingeleitet | Jefferies | Hold |
2022-07-11 | Herabstufung | Citigroup | Buy → Neutral |
2022-03-02 | Fortgesetzt | BofA Securities | Buy |
2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy |
2022-02-02 | Hochstufung | UBS | Neutral → Buy |
2022-01-31 | Hochstufung | Oppenheimer | Perform → Outperform |
2021-07-21 | Fortgesetzt | Cowen | Outperform |
2021-05-25 | Eingeleitet | Barclays | Overweight |
2021-04-01 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
2021-03-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
2020-07-28 | Eingeleitet | Wells Fargo | Overweight |
2020-04-24 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2020-04-03 | Eingeleitet | BofA/Merrill | Neutral |
2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
2020-03-05 | Eingeleitet | Citigroup | Buy |
2019-12-10 | Eingeleitet | CFRA | Sell |
2019-10-23 | Eingeleitet | Stifel | Hold |
2019-10-18 | Herabstufung | Canaccord Genuity | Buy → Hold |
2019-10-14 | Herabstufung | BTIG Research | Buy → Neutral |
2019-10-04 | Herabstufung | UBS | Buy → Neutral |
2019-10-03 | Herabstufung | Guggenheim | Buy → Neutral |
2019-08-06 | Hochstufung | JP Morgan | Neutral → Overweight |
2019-06-10 | Herabstufung | Northland Capital | Outperform → Market Perform |
2019-05-06 | Hochstufung | BTIG Research | Neutral → Buy |
2018-04-20 | Eingeleitet | Berenberg | Buy |
2018-02-22 | Bestätigt | Barclays | Overweight |
2018-01-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2017-11-03 | Hochstufung | Canaccord Genuity | Hold → Buy |
2017-09-15 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Insulet Corporation Aktie (PODD) Neueste Nachrichten
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know - Barchart.com
Beacon Investment Advisory Services Inc. Sells 33,261 Shares of Insulet Corporation $PODD - MarketBeat
Is Insulet Stock Outperforming the S&P 500? - Yahoo Finance
Mn Services Vermogensbeheer B.V. Increases Stock Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation (NASDAQ:PODD) Receives $343.06 Average Price Target from Brokerages - MarketBeat
Swedbank AB Buys 24,100 Shares of Insulet Corporation $PODD - MarketBeat
Automated Insulin Delivery Systems Market to Grow at 9.7% CAGR - openPR.com
Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Aaron Wealth Advisors LLC Acquires Shares of 925 Insulet Corporation $PODD - MarketBeat
Alecta Tjanstepension Omsesidigt Purchases 61,500 Shares of Insulet Corporation $PODD - MarketBeat
Strs Ohio Invests $1 Million in Insulet Corporation $PODD - MarketBeat
Czech National Bank Purchases 1,091 Shares of Insulet Corporation $PODD - MarketBeat
3,137 Shares in Insulet Corporation $PODD Bought by Marshall Financial Group LLC - MarketBeat
First Week of November 21st Options Trading For Insulet (PODD) - Nasdaq
Insulet (NASDAQ:PODD) Price Target Raised to $360.00 - MarketBeat
Toth Financial Advisory Corp Has $660,000 Stock Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Position Boosted by IFM Investors Pty Ltd - MarketBeat
Insulet (NASDAQ:PODD) Shares Down 4.2%Here's What Happened - MarketBeat
Finanzdaten der Insulet Corporation-Aktie (PODD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):